Hugel Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Hugel Inc (145020)
Hugel Inc stock price live, this page displays KQ 145020 stock exchange data. View the 145020 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Hugel Inc real time stock price chart below.
What Is the Hugel Inc Stock Price Today?
The Hugel Inc stock price today is 240,500.
What Is the Stock Symbol for Hugel Inc?
The stock symbol for Hugel Inc is "145020."
What Stock Exchange Does Hugel Inc Trade On?
Hugel Inc is listed and trades on the KOSDAQ stock exchange.
Is Hugel Inc a Good Stock to Buy?
Determining whether Hugel Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 145020 quote. (ISIN: KR7145020004)
What Is the Hugel Inc Stock Price Today?
The Hugel Inc stock price today is 240,500.
What Is the Stock Symbol for Hugel Inc?
The stock symbol for Hugel Inc is "145020."
What Stock Exchange Does Hugel Inc Trade On?
Hugel Inc is listed and trades on the KOSDAQ stock exchange.
Is Hugel Inc a Good Stock to Buy?
Determining whether Hugel Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 145020 quote. (ISIN: KR7145020004)
240,500
+4,500(+1.91%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
234,500
249,000
52 wk Range
208,500
369,000
145020 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
234,500249,000
52 wk Range
208,500369,000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
145020 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
360,563
Upside
+49.92%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
- Hugel Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Hugel Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Hugel Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Hugel Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Hugel Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Hugel Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Hugel Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Hugel Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
Analyst Ratings
15 Buy
1 Hold
0 Sell
Ratings:
16 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 360,563
(+49.92% Upside)
Earnings
Latest Release
May 07, 2026
EPS / Forecast
3,136.20 / 2,760.77
Revenue / Forecast
116.6B / 109.84B
Compare 145020 to Peers and Sector
Metrics to compare | 145020 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship145020PeersSector | |
|---|---|---|---|---|
P/E Ratio | 17.2x | −16.4x | −0.4x | |
PEG Ratio | 2.43 | −0.16 | 0.00 | |
Price/Book | 2.6x | 1.7x | 2.6x | |
Price / LTM Sales | 5.7x | 4.6x | 3.0x | |
Upside (Analyst Target) | 42.6% | 29.9% | 51.9% | |
Fair Value Upside | Unlock | 20.8% | 9.1% | Unlock |
Hugel, Inc. develops and manufactures biopharmaceuticals in South Korea and internationally. The company offers Botulinum Toxin, a white injectable dry powder in a transparent glass vial for use in the treatment of positive essential eyelid convulsion in adults over 18 years of age; improvement of severe lasso wrinkles associated with corrugator muscles and/or procerus muscle activities in adults aged between 18 and 65; treatment of upper limb stroke; and treatment of dynamic equinus foot deformity in children with cerebral palsy over 2 years of age, as well as improvement of external angles of secondary ideals related to orbicularis oculi muscle activity in adults aged between 19 and 65 under the Botulax, Regenox, Zentox, Reage, Magnion, Hugel Toxin, Juvenlife, Botulim, and Botoshot brands. It also provides hyaluronic acid filler under the Dermalax, and The Chaeum brand names; cosmetics under the Wellage brand; and medical devices under BlueRose brand name. Hugel, Inc. was founded in 2001 and is headquartered in Chuncheon-si, South Korea.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Hugel (145020) Stock Price Today?
The Hugel stock price today is 240,500 KRW.
What Stock Exchange Does Hugel Trade On?
Hugel is listed and trades on the KOSDAQ.
What Is the Stock Symbol for Hugel?
The stock symbol for Hugel is "145020."
What Is the Hugel Market Cap?
As of today, Hugel market cap is 2.55T KRW.
What Is Hugel's Earnings Per Share (TTM)?
The Hugel EPS (TTM) is 13,745.
When Is the Next Hugel Earnings Date?
Hugel will release its next earnings report on Aug 18, 2026.
From a Technical Analysis Perspective, Is 145020 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Hugel Stock Split?
Hugel has split 1 times.
How Many Employees Does Hugel Have?
Hugel has 594 employees.
What is the current trading status of Hugel (145020)?
As of Jul 10, 2026, Hugel (145020) is trading at a price of 240,500 KRW, with a previous close of 236,000 KRW. The stock has fluctuated within a day range of 234,500 KRW to 249,000 KRW, while its 52-week range spans from 208,500 KRW to 369,000 KRW.
What Is Hugel (145020) Price Target According to Analysts?
The average 12-month price target for Hugel is 360,563 KRW, with a high estimate of 430000 KRW and a low estimate of 300000 KRW. 15 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +49.92% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.